Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 1/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | THRA | P10827 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL6390523 | 1.00 | PSIP1 (0.61) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL6673936 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL8778748 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL588204 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL16087603 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL10616984 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL8778740 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL5963682 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL2446192 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 | |
| SCHEMBL27510240 | 0.98 | PSIP1 (0.59) | PSIP1KEAP1NFE2L2HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104010505-A | Pesticidal compositions and methods related thereto | DOW AGROSCIENCES LLC | 2014-08-27 | — | — | CN | claimed |
| EP-0939630-B1 | USE OF BENZOPYRANOLS TO TREAT NEUROLOGICAL DISORDERS | SMITHKLINE BEECHAM PLC (GB) | 2004-06-30 | — | — | EP | claimed |
| US-20030069300-A1 | Use of benzopyranols to treat neurological disorders | SMITHKLINE BEECHAM, PLC | 2003-04-10 | — | — | US | claimed |
| US-6492415-B2 | ESPECIALLY FOR TRIGEMINAL NEURALGIA AND NEUROPATHIC PAIN. | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-12-10 | — | — | US | claimed |
| US-20020010209-A1 | Use of benzopyranols to treat neurological disorders | PARSONS ANDREW (GB) | 2002-01-24 | — | — | US | claimed |
| EP-0764159-B1 | C -4 AMIDE SUBSTITUTED COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | SMITHKLINE BEECHAM PLC (GB) | 2000-08-09 | — | — | EP | claimed |
| EP-0939630-A1 | USE OF BENZOPYRANOLS TO TREAT NEUROLOGICAL DISORDERS | SMITHKLINE BEECHAM PLC (GB) | 1999-09-08 | — | — | EP | claimed |
| WO-1998011890-A1 | USE OF BENZOPYRANOLS TO TREAT NEUROLOGICAL DISORDERS | SMITHKLINE BEECHAM PLC (GB) | 1998-03-26 | — | — | WO | claimed |
| EP-0602914-B1 | Ink compositions for ink jet printing | XEROX CORP (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0764159-A1 | C -4 AMIDE SUBSTITUTED COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1997-03-26 | — | — | EP | claimed |
| WO-1995034547-A1 | C-4 AMIDE SUBSTITUTED COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1995-12-21 | — | — | WO | claimed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | claimed |
| CN-115697058-B | Agrochemical adjuvants | 禾大国际股份公开有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-115702132-B | Composition for enhancing nitrogen stabilizer, method and use thereof | 沃戴申生命科学美国有限责任公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-115334884-B | Clomazone composition for improving nitrogen nutrient use efficiency and plant growth | 沃戴申生命科学美国有限责任公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118696031-A | Aryltetrahydropyridine derivative or salt thereof, pest control agent containing the same, and method for using the same | 日本农药株式会社 | 2024-09-24 | — | — | CN | disclosed |
| WO-1991000280-A1 | 6-(HYDRONAPHTYL-1-ETHYL)-4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-PYRAN-2-ONES AND THE CORRESPONDING HYDROXY ACIDS | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1991-01-10 | — | — | WO | disclosed |
| US-4873278-A | Inhibition of irradiation yellowing in polysulfone compositions | GENERAL ELECTRIC COMPANY (US) | 1989-10-10 | — | — | US | disclosed |
| US-4485872-A | FLOW CONTROL AGENTS | PHILLIPS PETROLEUM COMPANY (US) | 1984-12-04 | — | — | US | disclosed |
| US-4028422-A | SEX ATTRACTANTS FOR FLIES | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069300-A1 | Use of benzopyranols to treat neurological disorders | TARDBP, HTT, GRIN3A | PSIP1 3502/4885KEAP1 3296/4885NFE2L2 1116/4885 |
| US-20020010209-A1 | Use of benzopyranols to treat neurological disorders | TARDBP, HTT, GRIN3A | PSIP1 3502/4885KEAP1 3296/4885NFE2L2 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.